Compile Data Set for Download or QSAR
maximum 50k data
Found 96 Enz. Inhib. hit(s) with all data for entry = 9120
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443131(US10654833, Compound 5)
Affinity DataIC50:  0.300nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443190(US10654833, Compound 102)
Affinity DataIC50:  0.700nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443199(US10654833, Compound 113)
Affinity DataIC50:  1.60nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443135(US10654833, Compound 13)
Affinity DataIC50:  1.60nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443174(US10654833, Compound 86)
Affinity DataIC50:  1.83nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443203(US10654833, Compound 117)
Affinity DataIC50:  1.90nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443200(US10654833, Compound 114)
Affinity DataIC50:  2.10nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443175(US10654833, Compound 87)
Affinity DataIC50:  2.5nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443142(US10654833, Compound 53)
Affinity DataIC50:  2.60nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443165(US10654833, Compound 77)
Affinity DataIC50:  2.80nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443218(US10654833, Compound 37)
Affinity DataIC50:  2.80nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443170(US10654833, Compound 82)
Affinity DataIC50:  3.20nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443189(US10654833, Compound 101)
Affinity DataIC50:  3.28nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443140(US10654833, Compound 39 | US10654833, Compound 67)
Affinity DataIC50:  3.30nMAssay Description:Compound binding to the ASK1 kinase active site was determined using the KINOMEscan Assay platform (DiscoverX, San Diego, Calif.). Briefly, ASK1-tagg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443140(US10654833, Compound 39 | US10654833, Compound 67)
Affinity DataIC50:  3.30nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443183(US10654833, Compound 95)
Affinity DataIC50:  3.40nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443209(US10654833, Compound 123)
Affinity DataIC50:  3.5nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443173(US10654833, Compound 85)
Affinity DataIC50:  3.60nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443208(US10654833, Compound 122)
Affinity DataIC50:  3.90nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443139(US10654833, Compound 35)
Affinity DataIC50:  4nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443207(US10654833, Compound 121)
Affinity DataIC50:  4.10nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443128(US10654833, Compound 2)
Affinity DataIC50:  4.30nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443159(US10654833, Compound 71)
Affinity DataIC50:  4.30nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443172(US10654833, Compound 84)
Affinity DataIC50:  4.30nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443178(US10654833, Compound 90)
Affinity DataIC50:  4.40nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443166(US10654833, Compound 78)
Affinity DataIC50:  4.60nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443202(US10654833, Compound 116)
Affinity DataIC50:  4.60nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443167(US10654833, Compound 79)
Affinity DataIC50:  4.60nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443185(US10654833, Compound 97)
Affinity DataIC50:  4.70nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443160(US10654833, Compound 72)
Affinity DataIC50:  4.70nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443141(US10654833, Compound 41)
Affinity DataIC50:  4.70nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443186(US10654833, Compound 98)
Affinity DataIC50:  4.90nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443184(US10654833, Compound 96)
Affinity DataIC50:  4.90nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443177(US10654833, Compound 89)
Affinity DataIC50:  4.90nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443176(US10654833, Compound 88)
Affinity DataIC50:  4.90nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443129(US10654833, Compound 3)
Affinity DataIC50:  4.90nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443148(US10654833, Compound 60)
Affinity DataIC50:  5nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443146(US10654833, Compound 58)
Affinity DataIC50:  5.10nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443149(US10654833, Compound 61)
Affinity DataIC50:  5.10nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443151(US10654833, Compound 63)
Affinity DataIC50:  5.10nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443205(US10654833, Compound 119)
Affinity DataIC50:  5.20nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443168(US10654833, Compound 80)
Affinity DataIC50:  5.20nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443196(US10654833, Compound 108)
Affinity DataIC50:  5.20nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443195(US10654833, Compound 107)
Affinity DataIC50:  5.20nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443127(US10654833, Compound 1)
Affinity DataIC50:  5.20nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443127(US10654833, Compound 1)
Affinity DataIC50:  5.20nMAssay Description:Compound binding to the ASK1 kinase active site was determined using the KINOMEscan Assay platform (DiscoverX, San Diego, Calif.). Briefly, ASK1-tagg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443137(US10654833, Compound 20)
Affinity DataIC50:  5.30nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443147(US10654833, Compound 59)
Affinity DataIC50:  5.30nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443143(US10654833, Compound 55)
Affinity DataIC50:  5.40nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Hepatikos Therapeutics

US Patent
LigandPNGBDBM443140(US10654833, Compound 39 | US10654833, Compound 67)
Affinity DataIC50:  5.40nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 96 total ) | Next | Last >>
Jump to: